Here's Why Nyxoah (NYXH) Could be Great Choice for a Bottom FisherZacks Investment Research • 10/20/26
Nyxoah Announces Preliminary Results for the Third Quarter of 2026 and Adjusts Revenue Guidance for 2026GlobeNewsWire • 10/19/26
Nyxoah Stock Down Despite First Genio Implant in U.S. BREATHE TrialZacks Investment Research • 09/08/26
Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® SystemGlobeNewsWire • 09/07/26
Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating ResultsGlobeNewsWire • 08/05/26
Nyxoah Touts Genio U.S. Launch Traction, Reimbursement Stability at Investor DayMarketBeat • 07/10/26
Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 9, 2026GlobeNewsWire • 06/19/26
$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial LaunchGlobeNewsWire • 06/10/26